Page last updated: 2024-09-03

sr 2640 and Asthma

sr 2640 has been researched along with Asthma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kreft, AF; Musser, JH1
Frølund, L; Madsen, F; Nielsen, J1

Reviews

1 review(s) available for sr 2640 and Asthma

ArticleYear
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
    Journal of medicinal chemistry, 1992, Jul-10, Volume: 35, Issue:14

    Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines

1992

Trials

1 trial(s) available for sr 2640 and Asthma

ArticleYear
Reproducibility of leukotriene D4 inhalation challenge in asthmatics. Effect of a novel leukotriene D4/E4-antagonist (SR 2640) on leukotriene D4-induced bronchoconstriction.
    Allergy, 1991, Volume: 46, Issue:5

    Topics: Adult; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Lung; Male; Middle Aged; Quinolines; Reproducibility of Results; SRS-A

1991